Merit Medical acquires View Point Medical for $140M, adding innovative OneMark technology to enhance breast tumor detection and localization solutions.
Rising incidence of breast cancer, growing adoption of breast-conserving surgeries, and increasing demand for minimally invasive and radiation-free localization technologies are the major factors ...
View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
The acquisition expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results